Biotech Values

[Whalatane]

There were reasons for the sharp sell off in some biotechs in March .... suspension of clinical trials , difficulty in recruiting because of Covid etc . Thats is now waning ....or will in the coming months .
Seriously doubt Biden will attack biotech any time soon when Pfizer and Moderna have just saved the planet ....or at least those countries that can pay for their vaccines.
Kiwi